Assessment of digital perfusion as a surrogate outcome in Raynaud's phenomenon clinical trials.

Digital perfusion, at rest or in response to a cold challenge, and whatever the method used, does not fulfill the criteria of a valid surrogate for existing patient-reported outcomes in RP trials.